RECRUITINGOBSERVATIONAL
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
About This Trial
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Age≥18 years.
2. Severe aortic stenosis with bicuspid anatomy.
3. NYHA≥2 and/or syncope and/or angina.
4. Patient judged by the Heart Team as indicated for TAVR.
Who Should NOT Join This Trial:
1. Age \<18 years
2. Asymptomatic patients
3. Pure aortic regurgitation.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Age≥18 years.
2. Severe aortic stenosis with bicuspid anatomy.
3. NYHA≥2 and/or syncope and/or angina.
4. Patient judged by the Heart Team as indicated for TAVR.
Exclusion Criteria:
1. Age \<18 years
2. Asymptomatic patients
3. Pure aortic regurgitation.
Treatments Being Tested
DEVICE
Transcatheter aortic valve replacement
Locations (1)
Cedars-Sinai Medical Center
Los Angeles, California, United States